SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-032128
Filing Date
2023-09-08
Accepted
2023-09-08 17:15:04
Documents
3
Period of Report
2023-09-08

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 473289
2 formpre14a_001.jpg GRAPHIC 62403
3 formpre14a_002.jpg GRAPHIC 54954
  Complete submission text file 0001493152-23-032128.txt   636163
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38022 | Film No.: 231246104
SIC: 2834 Pharmaceutical Preparations